Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis
Acta Dermato-Venereologica · 22.08.2023 · 103 · adv13382
DOI: 10.2340/actadv.v103.13382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 22.08.2023. Verfasst von Darya Pavlenko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, Miami, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Crisaborole, a phosphodiesterase 4 (PDE4) inhibitor, has been approved for the treatment of mild to moderate atopic dermatitis. Atopic dermatitis is often associated with increased pain. Using a mouse model, this study investigated whether crisaborole suppresses pain associated with atopic dermatitis and the potential mechanisms underlying it. The mouse model for atopic dermatitis was developed by repeatedly applying MC903. MC903-treated mice had increased spontaneous scratching (itch-related behaviour) and wiping behaviour (pain-related behaviour). Crisaborole was topically applied to the cheek skin of MC903-treated mice, and it reduced both itch- and pain-related behaviours in these mice. Immunofluorescence staining revealed that crisaborole reduced neutrophil infiltration and interaction of neutrophils with sensory neurones. Intradermal injection of S100A8/A9, proinflammatory neutrophil mediator, enhanced not only itch-related behaviours evoked by histamine or chloroquine, but also pain-related behaviours evoked by capsaicin. Calcium imaging of mouse dorsal root ganglion neurones revealed that pretreatment with S100A8/A9 significantly increased calcium responses to histamine and capsaicin, and the proportion of chloroquine-sensitive neurones. These findings suggest that the PDE4 inhibitor reduces itch and pain, in part by inhibiting infiltration of S100A8/A9-containing neutrophils in a mouse model of MC903-induced atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, Miami, USA.
- Department of Medical Pharmacology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey
ORCID-Profile: Zeynep Todurga Seven
Förderung
- Pfizer
Zitieren
APA
Pavlenko, D., Todurga Seven, Z., Bystrom, L., Markan, A., Verpile, R., Ishida, H., & Akiyama, T. (2023). Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis. Acta Dermato-Venereologica, 103, adv13382. https://doi.org/10.2340/actadv.v103.13382
Vancouver
Pavlenko D, Todurga Seven Z, Bystrom L, Markan A, Verpile R, Ishida H, et al. Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis. Acta Dermato-Venereologica. 2023;103:adv13382. doi:10.2340/actadv.v103.13382
BibTeX
@article{Pavlenko2023,
author = {Pavlenko, Darya and Todurga Seven, Zeynep and Bystrom, Lauren and Markan, Anika and Verpile, Rebecca and Ishida, Hirotake and Akiyama, Tasuku},
title = {Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis},
journal = {Acta Dermato-Venereologica},
year = {2023},
volume = {103},
pages = {adv13382},
doi = {10.2340/actadv.v103.13382}
}
EUVIMED